Globus Medical, Inc. (GMED)
NYSE: GMED · Real-Time Price · USD
82.63
+0.69 (0.84%)
Dec 20, 2024, 4:00 PM EST - Market closed
Globus Medical Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | 91.51 | 122.87 | 190.17 | 149.19 | 102.29 | 155.21 | Upgrade
|
| Depreciation & Amortization | 256.96 | 144.73 | 68.25 | 69.87 | 62.87 | 52.73 | Upgrade
|
| Loss (Gain) From Sale of Assets | 2.76 | 1.54 | 0.3 | 0.46 | 0.81 | 0.87 | Upgrade
|
| Asset Writedown & Restructuring Costs | 12.61 | - | 0.15 | 34.31 | 24.42 | - | Upgrade
|
| Loss (Gain) From Sale of Investments | -0.06 | 0.79 | 5.39 | 2.78 | 0.59 | -1.09 | Upgrade
|
| Stock-Based Compensation | 54.73 | 52.74 | 32.81 | 30.59 | 27.07 | 26.09 | Upgrade
|
| Provision & Write-off of Bad Debts | 15.04 | 3.66 | -0 | 1.2 | 2.96 | 3.03 | Upgrade
|
| Other Operating Activities | 151.63 | 33.76 | -13.34 | 5.13 | 15.38 | 8.59 | Upgrade
|
| Change in Accounts Receivable | -113.51 | -49.91 | -50.84 | -25.9 | 10.7 | -18.31 | Upgrade
|
| Change in Inventory | -29.32 | -70.33 | -61.75 | -11.97 | -50.11 | -50.02 | Upgrade
|
| Change in Accounts Payable | -4.98 | -14.22 | 14.42 | 3.68 | -6.35 | 0.77 | Upgrade
|
| Change in Income Taxes | -18.67 | -0.41 | -2.89 | 5.21 | 1.66 | -0.67 | Upgrade
|
| Change in Other Net Operating Assets | -3.74 | 18.28 | -4.21 | 11.72 | 6.52 | -5.22 | Upgrade
|
| Operating Cash Flow | 414.97 | 243.5 | 178.47 | 276.27 | 198.79 | 171.98 | Upgrade
|
| Operating Cash Flow Growth | 104.62% | 36.44% | -35.40% | 38.98% | 15.59% | -5.32% | Upgrade
|
| Capital Expenditures | -121.2 | -78.27 | -74.05 | -56.9 | -63.66 | -70.75 | Upgrade
|
| Cash Acquisitions | -17.64 | -296.03 | -31.44 | -34.49 | -33.48 | -23.8 | Upgrade
|
| Investment in Securities | 387.52 | 677.27 | -4.88 | -284.55 | -20.18 | -45.73 | Upgrade
|
| Investing Cash Flow | 248.69 | 302.97 | -110.36 | -375.94 | -117.32 | -140.28 | Upgrade
|
| Issuance of Common Stock | 42.2 | 12.4 | 41.72 | 63.5 | 72.32 | 31.04 | Upgrade
|
| Repurchase of Common Stock | -327.76 | -236.18 | -144.49 | - | -104.67 | - | Upgrade
|
| Other Financing Activities | -39.13 | -8.04 | -7.19 | -9.35 | -6.32 | -6.6 | Upgrade
|
| Financing Cash Flow | -324.7 | -231.82 | -109.96 | 54.15 | -38.66 | 24.44 | Upgrade
|
| Foreign Exchange Rate Adjustments | 4.19 | 2.18 | -0.75 | -0.81 | 0.87 | -0.16 | Upgrade
|
| Net Cash Flow | 343.15 | 316.83 | -42.6 | -46.33 | 43.67 | 55.98 | Upgrade
|
| Free Cash Flow | 293.77 | 165.23 | 104.42 | 219.38 | 135.14 | 101.23 | Upgrade
|
| Free Cash Flow Growth | 127.61% | 58.23% | -52.40% | 62.34% | 33.50% | -16.99% | Upgrade
|
| Free Cash Flow Margin | 11.85% | 10.53% | 10.21% | 22.90% | 17.13% | 12.89% | Upgrade
|
| Free Cash Flow Per Share | 2.16 | 1.44 | 1.02 | 2.12 | 1.34 | 0.99 | Upgrade
|
| Cash Income Tax Paid | 152.9 | 100.59 | 77.82 | 45.03 | 25.44 | 34.14 | Upgrade
|
| Levered Free Cash Flow | 473.36 | -346.92 | 74.96 | 160.53 | 88.28 | 47.6 | Upgrade
|
| Unlevered Free Cash Flow | 478.1 | -346.92 | 74.96 | 160.53 | 88.28 | 47.6 | Upgrade
|
| Change in Net Working Capital | -40.72 | 637.06 | 99.71 | 4.81 | 10.18 | 70.94 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.